Autologous Osteoperiosteal Transplantation for the Treatment of Severe Osteochondral Lesions of the Talus

Recruiting Observational Study
Osteochondral Lesion of Talus Autologous Osteoperiosteal Transplantation
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 60
Sex
Any
Study type
Observational
Participants needed
60 (estimated)
Sponsor
Peking University Third Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this clinical trial is to establish a multicenter prospective cohort of patients with severe osteochondral lesion of the talus (OLT), evaluate the clinical efficacy of autologous osteoperiosteal transplantation and the incidence of postoperative donor-site morbidity. The main questions it aims to answer are: Does autologous osteoperiosteal transplantation have good clinical outcomes i…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Chronic ankle pain, diagnosed as Osteochondral Lesions of the Talus (OLT); * Hepple V OLT on the medial side of the talus or the diameter of the lesion ≥ 8 mm; * Conservative treatment of at least 3 months fails to relieve symptoms; * Willingness to voluntarily participate in …
Contacts

Qinwei Guo, MD

+86 18601129252

guoqinwei@vip.sina.com

CONTACT

Qixian Shen, MD

+86 13318038398

bjmusqx@163.com

CONTACT